SRZN
Surrozen, Inc./DE
$22.81
-0.38 (-1.64%)
At close · Jul 13
Market Cap
$264.83M
Shares
11,610,371
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$22.81
Open$23.19
Day$21.54–23.70
52W$8.20–35.00
Avg vol 30d166K
Short int710K · 6.1% float · 3.1d
Short vol98%
Last earningsMar 22, 2023
DataJan 2021–Jul 2026
Filing10-Q · May 6
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 17.2 · elevated
Equity put/call 0.67
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+3%
above
Price vs 50-day avg
−12%
below
RSI (14)
41
neutral
MACD trend
Negative
52-week position
55%
mid-range
Momentum
relative strength
1-month return
−2%
trailing
6-month return
+14%
trailing
YTD return
+1%
this year
Relative strength
+6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $26 › 200d $22 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +15 funds added
Insider flow
Distributing
Net -$271.5K over 90 days · 100% sells
Short interest
Rising
6.11% of float · ▲ +105.1% MoM · 3.1 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
58 holders — near 2-yr high, broad support
Squeeze score
67
elevated · 0–100
Fundamentals
Revenue growth
−67%
Y/Y
EPS growth
−49%
Y/Y
Free cash flow
$-30.4M
Balance sheet
$89.2M
net cash
Quant / Vol
risk profile
Volatility
73%
annualized · 1-yr
Max drawdown
−39%
past year
ATR
8.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+3%
Bullish
Price vs 50-day avg
−12%
Bearish
RSI (14)
41
Neutral
MACD trend
Negative
Bearish
52-week position
55%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $26 › 200d $22 — 50d above 200d
Institutional flow
Accumulating
+7% holders QoQ · +15 funds added
Insider flow
Distributing
Net -$271.5K over 90 days · 100% sells
Short interest
Rising
6.11% of float · ▲ +105.1% MoM · 3.1 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Multi-yr high
58 holders — near 2-yr high, broad support
Price context
position in its 52-week range
52-wk low $8
Now $23 · 55%
52-wk high $35
vs 200-day avg +3%
vs 50-day avg -12%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SRZN
this stock
Surrozen, Inc./DE
|
$264.83M | +0.9% | -67.4% | — | 6.1% |
|
ONC
BeOne Medicines Ltd.
|
$439.30B | +0.0% | +22179.2% | 894.0 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.89B | +5.9% | +46.2% | 28.5 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.52B | -14.0% | +20.8% | 16.2 | 3.3% |
|
ARGX
Argenx SE
|
$54.76B | +4.2% | — | — | 2.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SRZN | -3.6% | -2.4% | +14.1% | -12.1% | +0.9% |
| SPY | -0.3% | +1.6% | +8.3% | +0.3% | +9.9% |
| vs SPY | -3.3% | -4.0% | +5.7% | -12.4% | -8.9% |